Loading...
Market
How much will Abiologics raise in its next funding round by June 30, 2025?
2
Resolution / Starting Odds
Less than $100 million • 25%
$100 million to $199 million • 25%
$200 million to $299 million • 25%
$300 million or more • 25%
Official press release or announcement from Abiologics
Story
Flagship Pioneer Launches Abiologics, Founded by Noubar Afeyan, to Develop Synteins™ Using AI and High Throughput Chemical Protein Synthesis
Jul 23, 2024, 12:22 PM
Flagship Pioneer's new venture, Abiologics, aims to revolutionize the field of therapeutics by developing a new class of programmable medicines known as Synteins™. Utilizing generative artificial intelligence and high-throughput chemical protein synthesis, Abiologics seeks to create supranatural biologics that can overcome the limitations of existing medicines. The company, founded by Noubar Afeyan, focuses on designing biologics composed of artificial building blocks at scale, with the goal of providing life-changing treatments to patients. This initiative marks a significant advancement in the drug development landscape, addressing challenges related to usability, administration routes, and tolerability of current biologics and protein drugs.
View original story
Similar markets
No additional funding • 25%
Up to $10 million • 25%
$10 million to $50 million • 25%
Over $50 million • 25%
Less than $50M • 25%
$50M to $100M • 25%
$100M to $150M • 25%
More than $150M • 25%
Less than $5 million • 25%
$5 million to $10 million • 25%
$10 million to $20 million • 25%
More than $20 million • 25%
Less than $2 billion • 25%
$2 billion to less than $4 billion • 25%
$4 billion to less than $6 billion • 25%
$6 billion or more • 25%
Less than $20 million • 25%
$20 million to $50 million • 25%
$51 million to $100 million • 25%
More than $100 million • 25%
Below $800M • 25%
$800M - $899M • 25%
$900M - $999M • 25%
$1B or more • 25%
Less than $20M • 25%
$20M to $40M • 25%
$40M to $60M • 25%
More than $60M • 25%
Less than $50M • 25%
$50M - $100M • 25%
$100M - $150M • 25%
More than $150M • 25%
Above $1 billion • 25%
Between $750 million and $1 billion • 25%
Between $500 million and $750 million • 25%
Below $500 million • 25%
Below $1 billion • 25%
$1 billion to $2 billion • 25%
$2 billion to $3 billion • 25%
Above $3 billion • 25%